Restoration of defective cross-presentation in tumors by gemcitabine

Tumor antigen cross-presentation by dendritic cells (DCs) to specific CD8(+) T cells is central to antitumor immunity. Although highly efficient in draining lymph nodes, it is defective within the tumor site itself. Importantly, an immunogenic chemotherapy, gemcitabine, reverses this defect, allowin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: McDonnell, Alison M, Joost Lesterhuis, W, Khong, Andrea, Nowak, Anna K, Lake, Richard A, Currie, Andrew J, Robinson, Bruce WS
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2015
Témata:
Author's View
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485774/
https://ncbi.nlm.nih.gov/pubmed/26155402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1005501
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky